Výsledky vyhledávání - "Lewis H. Silver"

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar

Autor: Niran J. Amar, Frank C. Hampel, Bradley F. Marple, Michael J. Brubaker, Margaret Drake, G. Michael Wall, Julius H. van Bavel, Dale Mohar, Lewis H. Silver, Darell Turner, Peter S. Roland, Paul H. Ratner

Publikováno v: Annals of Allergy, Asthma & Immunology. 95:474-479

Background A nasal spray containing the antiallergy agent olopatadine hydrochloride is being developed for the treatment of seasonal allergic rhinitis (SAR) to mountain cedar. Objective To evaluate the safety and efficacy of 2 concentrations of olopa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3fbb88a1b3d328ae1683104fa1e68ea
https://doi.org/10.1016/s1081-1206(10)61174-x

Zobrazit plný text záznamu

Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension

Autor: M.V. W. Bergamini, Alberta A Davis, Scott Krueger, Lewis H. Silver, Alan L. Weiner, E. Kenneth Sullivan, Stella M. Robertson, Peter A. Netland

Publikováno v: Advances in Therapy. 20:149-163

Two prospective, controlled, multicenter, double-masked studies--one lasting 6 months (n=594) and the other, 12 months (n=787)--examined the intraocular pressure (IOP)-lowering efficacy of travoprost in 1381 black and nonblack patients with open-angl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd8dbe9884de176088c0e9a924282bd
https://doi.org/10.1007/bf02850202

Zobrazit plný text záznamu

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure

Autor: Marla Ratliff, Alan L. Weiner, Alberta A Davis, E. Kenneth Sullivan, Jess T. Whitson, Ronald L. Fellman, F. Darell Turner, Lewis H. Silver

Publikováno v: Ophthalmology. 109:998-1008

Objective To compare the safety and intraocular pressure (IOP)-lowering efficacy of once-daily travoprost (0.0015% and 0.004%) to twice-daily timolol 0.5%. Design Prospective, 6-month, randomized, controlled, multicenter, double-masked, phase III stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1da46541cc90aef53386bd2a6c3d411a
https://doi.org/10.1016/s0161-6420(02)01010-2

Zobrazit plný text záznamu

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

Autor: Jaime E. Dickerson, Russell M. Andrew, Lewis H. Silver, Theresa A. Landry, E. Kenneth Sullivan, Alberta A Davis, Michael V. W. Bergamini, Peter A. Netland, Alan L. Weiner, Sushanta Mallick, Stella M. Robertson

Publikováno v: American Journal of Ophthalmology. 132:472-484

● PURPOSE: This study evaluated the safety and intraocular pressure–lowering efficacy of two concentrations of travoprost (0.0015% and 0.004%) compared with latanoprost 0.005% and timolol 0.5% in patients with open-angle glaucoma or ocular hypert

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a0826d79c3b67782df4228fe0c127e70
https://doi.org/10.1016/s0002-9394(01)01177-1

Zobrazit plný text záznamu

Long-term intraocular pressure–lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with timoptic XE 0.5% in a 12-month study11All proprietary rights for this study are retained by Alcon Research, Ltd

Autor: Howard I. Schenker, Lewis H. Silver

Publikováno v: American Journal of Ophthalmology. 130:145-150

PURPOSE: To evaluate the long-term intraocular pressure–lowering efficacy and safety of timolol maleate gel-forming solution 0.5% (Timolol GFS 0.5%, Alcon Research Ltd, Fort Worth, Texas) compared with Timoptic XE 0.5% (Merck, Inc, West Point, Penn

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::219acba1224c54305b46a8cd3af099f3
https://doi.org/10.1016/s0002-9394(00)00458-x

Zobrazit plný text záznamu

Clinical efficacy and safety of brinzolamide (Azopt™), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension

Autor: Lewis H. Silver

Publikováno v: American Journal of Ophthalmology. 126:400-408

Purpose To determine the intraocular pressure-lowering efficacy and safety of brinzolamide 1.0%, compared with dorzolamide 2.0% and timolol 0.5%. Methods A multicenter, double-masked, prospective, parallel-group study was conducted to compare brinzol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d091fdf37ddac69f5417eb67a720aa3e
https://doi.org/10.1016/s0002-9394(98)00095-6

Zobrazit plný text záznamu

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis

Autor: Susan L. Potts, J. Rod Barnes, William E. Berger, Eli O. Meltzer, Paul H. Ratner, Frank C. Hampel, David I. Bernstein, Lewis H. Silver, Albert F. Finn, Bradley F. Marple, G. Michael Wall, Michael J. Brubaker, Lawrence V. Larsen, Carolyn Dimas, Peter S. Roland

Publikováno v: Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 95(6)

A nasal spray containing the antiallergy agent olopatadine hydrochloride is being developed for the treatment of seasonal allergic rhinitis (SAR).To evaluate the safety and efficacy of 2 concentrations of olopatadine nasal spray vs placebo in patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bf95d5c08409f6e65111ee0c2de7365
https://pubmed.ncbi.nlm.nih.gov/16400902

Zobrazit plný text záznamu

Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis

Autor: Dawnelle B. Montgomery, Adrienne M. Woodside, Lewis H. Silver

Publikováno v: Survey of ophthalmology. 50

Five independent, multicentered, double-masked, parallel, controlled studies were conducted to determine the safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis. Patients were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38606cd52637e138293b5c56b6744269
https://pubmed.ncbi.nlm.nih.gov/16257311

Zobrazit plný text záznamu

The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1

Autor: Marlene R. Moster, Charles F. Bosworth, Jess T. Whitson, David T. Wells, Katherine I. Ochsner, Jaime E. Dickerson, Theresa A. Landry, Michael V.W. Bergamini, John E. James, Lewis H. Silver, Russell M. Andrew, E. Kenneth Sullivan

Publikováno v: Ophthalmology. 113(8)

Purpose The safety and intraocular pressure (IOP)-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1 were evaluated and compared with brimonidine tartrate 0.15% preserved with chlorine dioxide in patients with open-angle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb40defb6e774996c07a1e7fe26fdacd
https://pubmed.ncbi.nlm.nih.gov/16877072

Zobrazit plný text záznamu

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure

Autor: Marla D. Sircy, Lewis H. Silver, Johan Przydryga, F. Darell Turner, Russell M. Andrew, Stella M. Robertson, Michael V.W. Bergamini, Alan L. Weiner, Theresa A. Landry, Harvey Dubiner

Publikováno v: Clinical therapeutics. 26(1)

Prostaglandin analogues are effective ocular hypotensive agents and are being used increasingly in the treatment of elevated intraocular pressure (IOP). These agents are typically dosed once daily.A pilot study was conducted to evaluate the duration

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::776e32ec3f471308fd81957ab3a02ee2
https://pubmed.ncbi.nlm.nih.gov/14996520

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání